CTOR
CITIUS ONCOLOGY, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$0.54
−6.40%Oct 26, 2026, 20:30 UTC
Citius Oncology reported 792 wholesaler units and 950 institutional vial orders in Q4 2026, with 54 institutions ordering; wholesaler units rose 120% from the prior quarter, while institutional vial orders increased from 926.
Aug 14, 2026, 00:00 UTC
Citius Oncology, Inc. reported its Q3 2026 financial results, with revenue of $1.5 million and a net loss of $8.9 million.